The Latest Breaking News from Cancer

'Unprecedented' cancer jab can destroy whole tumours

An injection that can eradicate tumours in patients with very limited treatment options has been hailed by cancer specialists after an international trial.

AAP · May 30

Doctors hail cancer injection that can destroy entire tumors

The results of the trial will be presented during the American Society of Clinical Oncology annual meeting in Chicago

The Independent UK · May 30

Cancer jabs destroy whole tumours in treatment-resistant cases, trial shows

Head and neck cancer is the sixth most common cancer worldwide, and it affects around 12,800 people in the UK each year.

Evening Standard · May 30

Targeted drug shows promise for people with advanced bowel cancer in early trial

One patient taking part in the trial said the therapy has given her a ‘new lease of life’.

Evening Standard · May 30

Cancer-detecting blood test ‘feasible at scale’ on NHS

IN FULL

The Independent UK · May 30

Poop tests and blood tests join colonoscopy as options for colorectal cancer screening

It’s increasingly common to see headlines and social media conversations about the rise in colorectal cancer among younger adults. In fact, the growing incidence of colorectal cancer in people under age 50 helped drive the American Cancer Society’s 2018 decision to recommend lowering the recommended age for average-risk screening from…

The Conversation · May 30

Trial of multi-cancer blood test among 142,000 NHS patients fails to meet main aim

Results presented at oncology conference in Chicago show Galleri test failed to reduce late-stage cancer diagnoses

The Guardian - UK · May 30

New blood test ‘offers genuine hope’ it can detect deadly cancers before symptoms appear

The test is ‘feasible at scale’ on the NHS, say researchers

The Independent UK · May 30

Galleri blood test ‘feasible at scale’ on NHS, say experts

The NHS-Galleri trial is exploring how well the blood test works within the health service, alongside screening, to pick up cancer cases earlier.

Evening Standard · May 30

IDEXX Laboratories Touts AI Push, inVue Dx Momentum at Stifel Conference

IDEXX Laboratories (NASDAQ:IDXX) President and CEO Michael Erickson used a Stifel investor conference appearance to emphasize the company’s innovation pipeline, expanding commercial reach and growing use of software and artificial intelligence across veterinary diagnostics. Erickson, who recently b

MarketBeat · May 30